Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-10-19
2000-06-06
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424450, 435325, 4353201, 435455, 435458, 536 231, A01N 4304
Patent
active
060718900
ABSTRACT:
Novel cationic amphiphiles are provided that facilitate transport of biologically active (therapeutic) molecules into cells. The amphiphiles contain lipophilic groups derived from steroids, from mono or dialkylamines, or from alkyl or acyl groups; and cationic groups, protonatable at physiological pH, derived from amines, alkylamines or polyalkylamines. There are provided also therapeutic compositions prepared typically by contacting a dispersion of one or more cationic amphiphiles with the therapeutic molecules. Therapeutic molecules that can be delivered into cells according to the practice of the invention include DNA, RNA, and polypeptides. Representative uses of the therapeutic compositions of the invention include providing gene therapy, and delivery of antisense polynucleotides or biologically active polypeptides to cells. With respect to therapeutic compositions for gene therapy, the DNA is provided typically in the form of a plasmid for complexing with the cationic amphiphile. Novel and highly effective plasmid constructs are also disclosed, including those that are particularly effective at providing gene therapy for clinical conditions complicated by inflammation. Additionally, targeting of organs for gene therapy by intravenous administration of therapeutic compositions is described.
REFERENCES:
patent: 4394448 (1983-07-01), Szoka et al.
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 4958013 (1990-09-01), Letsinger
patent: 4971803 (1990-11-01), Li et al.
patent: 5004737 (1991-04-01), Kim et al.
patent: 5171678 (1992-12-01), Behr et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5283185 (1994-02-01), Epand et al.
patent: 5334761 (1994-08-01), Gebeyehu et al.
patent: 5416203 (1995-05-01), Letsinger
D. Litzinger et al., "Fate of Cationic Liposomes and their Complex with Oligonucleotide In Vivo", Biochimica et Biophysics Acta, 1281, 1996, pp. 139-149.
N. Egilmez et al., "Evaluation and Optimization of Different Cationic Liposome Formulations for In Vivo Gene Transfer", Biochemical and Biophysical Research Communications, 221, 1996, pp. 169-173.
V. Dzau et al., "Fusigenic Viral Liposome for Gene Therapy in Cardiovascular Diseases", Proceedings of the National Academy of Sciences, USA, 93, 1996, pp. 11421-11425.
M. Tsukamoto et al., "Gene Transfer and Expression in Progeny after Intravenous DNA Injection into Pregnant Mice", Nature Genetics, 9, 1995, pp. 243-248.
A. Thierry et al., "Systemic Gene Therapy: Biodistribution and Long-Term Expression of a Transgene in Mice", Proceedings of the National Academy of Sciences, USA, 92, 1995, pp. 9742-9746.
R. Mahato et al., "In Vivo Disposition Characteristics of Plasmid DNA Complexed with Cationic Liposomes", Journal of Drug Targeting, 3, 1995, pp. 149-157.
D. Lew et al., "Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice", Human Gene Therapy, 6, 1995, pp. 553-564.
N. Zhu et al., "Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice", Science, 261, 1993,pp. 209-211.
E. Nabel et al., "Recombinant Fibroblast Growth Factor-1 Promotes Intimal Hyperplasia and Angiogenesis in Arteries In Vivo", Nature, 362, 1993,pp. 844-846.
E. Nabel et al., "Direct Transfer of Transforming growth Factor .beta.1 Gene into Arteries Stimulates Fibrocellular Hyperplasia", Proceedings of the National Academy of Sciences, USA, 90, 1993, pp. 10759-10763.
K. Brigham et al., "Expression of Human Growth Hormone Fusion Genes in Cultured Lung Endothelial Cells and in the Lungs of Mice", American Journal of Respiratory Cell and Molecular Biology, 8, 1993,pp. 209-213.
M. Stewart et al., "Gene Transfer In Vivo with DNA-Liposome Complexes: Safety and Acute Toxicity in Mice", Human Gene Therapy, 3, 1992,pp. 267-275.
E. Nabel et al., "Gene Transfer In Vivo with DNA-Liposome Complexes: Lack of Autoimmunity and Gonadal Localization", Human Gene Therapy, 3, 1992,pp. 649-656.
C. Lim et al., "Direct In Vivo Gene Transfer Into the Coronary and Peripheral Vasculatures of the Intact Dog", Circulation, 83, 1991, pp. 2007-2011.
E. Nabel et al., "Site-Specific Gene Expression in Vivo By Direct Gene Transfer into the Arterial Wall", Science, 249, 1990, pp. 1285-1288.
K. Brigham et al., "Rapid Communication: In vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene Using a Liposome Vehicle", The American Journal of the Medical Sciences, 298, 1989, pp. 278-281.
L. Feldman et al., "Perspectives Of Arterial Gene Therapy For The Prevention Of Restenosis", Cardiovascular Research, 32, 1996,pp. 194-207.
D. Stephan, et al,. "A New Cationic Liposome DNA Complex Enhances the Efficiency of Arterial Gene Transfer In Vivo", Human Gene Therapy, 7, 1996,pp. 1803-1812.
J. Zhu et al., "A Continuous Intracerebral Gene Delivery System for In Vivo Liposome-Mediated Gene Therapy", Gene Therapy, 3, 1996, pp. 472-476.
A. Canonico et al., "Aerosol and Intravenous Transfection of Human .alpha.1-Antitrypsin Gene to Lungs of Rabbits", American Journal of Respiratory Cell and Molecular Biology, 10, 1994, pp. 24-29.
Y. Liu et al., "Cationic Liposome-mediated Intravenous Gene Delivery", The Journal of Biological Chemistry, 270, 1995,pp. 24864-24870.
G. McLachlan et al., "Evaluation In Vitro and In Vivo of Cationic Liposome-Expression Construct Complexes for Cystic Fibrosis Gene Therapy" Gene Therapy, 2, 1995, pp. 614-622. 0.
Leventis et al., "Interactions of Mammalian Cells With Lipid Dispersions Containing Novel Metabolizable Cationic Amphiphiles", Biochimica et Biophysica Acta, 1023, 1990, pp. 124-132.
H. Ueno, "Adenovirus-Mediated Gene Transfer into Injured Arteries: Quantitative Analysis of Repeated Administration", Gerontology, 42(suppl. 1), 1996,pp. 25-36.
K. Patel et al., "Modification of Vesicle Surfaces with Amphiphilic Sterols. Effect on Permeability and In Vivo Tissue Distribution", Biochimica et Biophysica Acta, 814, 1985,pp. 256-264.
K. Moore et al., "Squalamine: An Aminosterol Antibotic from the Shark", Proceedings of the National Academy of Sciences USA, 90, 1993,pp. 1354-1358.
J. Conary et al., "Protection of Rabbit Lungs from Endotoxin Injury by In Vivo Hyperexpression of the Prostaglandin G/H Synthase Gene", Journal of Clinical Investigation, 93, 1994,pp. 1834-1840.
J. Guy-Caffey et al., "Novel Polyaminolipids Enhance the Cellular Uptake of Oligonucleotides", The Journal of Biological Chemistry, 270, 1995,pp. 31391-31396.
J. Janne, et al., "Polyamines: From Molecular Biology to Clinical Applications", Annals of Medicine, 23, 1991,pp. 241-259.
N. Caplen, et al., "Liposome Mediated CFTR Gene Transfer to the Nasal Epithelium of Patients with Cystic Fibrosis", Nature Medicine, 1, 1995,pp. 39-46.
J-S. Remy et al., "Gene Transfer with a Series of Lipophilic DNA Binding Molecules", Bioconjugate Chemistry, 5, 1994,pp. 647-654.
J-P. Behr, "Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy", Bioconjugate Chemistry, 5, 1994, pp. 382-389.
J. Felgner, et al., "Enhanced Gene Delivery and Mechanism Studies with a Novel Series of Cationic Lipid Formulations", The Journal of Biological Chemistry, 269, 1994,pp. 2550-2561.
F. Barthel et al., "Gene Transfer Optimization with Lipospermine-Coated DNA", DNA and Cell Biology, 12, 1993, pp. 553-560.
J-P. Behr, "Synthetic Gene-Transfer Vectors", Accounts of Chemical Research, 26, 1993,pp. 274-278.
P. Hoet, et al., "Kinetics and Cellular Localization of Putrescine Uptake in Human Lung Tissue", Thorax, 48, 1993,pp. 1235-1241.
J. Felgner, et al., "Cationic Lipid-Mediated Delivery of Polynucleotides", Methods (A Companion to Methods in Enzymology), 5, 1993,pp. 67-75.
X. Gao, et al., "A Novel Cationic Liposome Reagent for Efficient Transfection of Mammalian Cells", Biochemical and Biophysical Research Communications, 179, 1991,pp. 280-285.
J. Rose, et al., "A New Cationic Liposome Reagent Mediating Nearly Quantitative Transfection of Animal Cells", Biotechniques, 10, 1991, pp. 520-525.
J. Loeffler, et al., "Lipopolyamine-Mediated Transfection Allows Gene Expression Studies in Primary Neuronal Cells", Journa
Bagley Rebecca G.
Cheng Seng H.
Eastman Simon J.
Harris David J.
Lee Edward R.
Campell Bruce R.
Genzyme Corporation
Nguyen Daug Trong
LandOfFree
Organ-specific targeting of cationic amphiphile/DNA complexes fo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organ-specific targeting of cationic amphiphile/DNA complexes fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organ-specific targeting of cationic amphiphile/DNA complexes fo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2213668